Hypha Labs, Inc.
FUNI - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$376.96K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $376,961.00 |
|---|---|
| Enterprise Value | $2.17 Million |
| Earnings per Share | $-0.02 |
| Beta | 1.35 |
| Outstanding Shares | 163,895,977 |
Return
| Return on Equity | 61.73% |
|---|---|
| Return on Assets | -2789.42% |
| Return on Invested Capital | 99.37% |
Valuation & Multiples
| P/E Ratio | -0.18 |
|---|---|
| PEG | 0.4 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.43 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.83 |
| Debt to Equity | -0.58 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Hypha Labs, Inc.
5 employees
CEO: A. Stone Douglass
Hypha Labs, Inc. focuses on the investigation, development, and market release of bioreactor systems across the United States. Their key offering is the Hypha Micropearl bioreactor, a specialized household device engineered to rapidly cu...